WAM
MBOT icon

Wealthspire Advisors (Maryland)’s Microbot Medical MBOT Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-9
Closed – – 2518
2018
Q1 		$0 Hold
9
– – ﹤0.01% 2587
2017
Q4 		$0 Hold
9
– – ﹤0.01% 2507
2017
Q3 		$0 Hold
9
– – ﹤0.01% 2372
2017
Q2 		$0 Hold
9
– – ﹤0.01% 2241
2017
Q1 		$1K Hold
9
– – ﹤0.01% 1816
2016
Q4 		$1K Hold
9
– – ﹤0.01% 1656
2016
Q3 		$2K Hold
9
– – ﹤0.01% 1557
2016
Q2 		$1K Hold
9
– – ﹤0.01% 1613
2016
Q1 		$4K Hold
9
– – ﹤0.01% 1395
2015
Q4 		$6K Buy
+9
New +$6.61K ﹤0.01% 1310

Other funds holding MBOT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s MBOT Position: Q2 2018 in Review

Wealthspire Advisors (Maryland) sold out of Microbot Medical (MBOT) in Q2 2018, closing a stake of 9 shares.

Wealthspire Advisors (Maryland) first reported a position in MBOT in Q4 2015 and held it in 10 quarters. The position peaked at $6K in Q4 2015. 26 funds tracked by Wall St. Rank hold MBOT as of Q2 2018.

  • Wealthspire Advisors (Maryland) reported no remaining Microbot Medical position as of Q2 2018 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 9 Microbot Medical shares in Q2 2018.
  • Wealthspire Advisors (Maryland) first reported a position in Microbot Medical in Q4 2015 and held it in 10 quarters.
  • Wealthspire Advisors (Maryland)'s Microbot Medical position peaked at $6K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2018.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2018, filed 8 Aug 2018.